Veeva Systems INC Stock: price and insider trades · United States · SEC (Form 4)Track the Veeva Systems INC stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Veeva Systems INC has logged 583 reports. Market capitalisation: €44.8bn. The latest transaction was filed on 3 September 2026 (Levée d'options). Among the most active insiders: Schwenger Thomas D.. All data is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate Veeva Systems INC Buy (bullish), based on 27 analysts. Average price target: US$294.07.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,094 of 29,062 companies
FCF yld 3.2%
Earn yld 2.0%
EV/EBITDA 47.0x
ROE 14%
Gross mgn 76%
Net mgn 28%
Debt/EBITDA 0.1x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 September 2026
All Executives583 Thresholds0 Prospectus0 Other0
Declarations 583 total
◇ Director · Executives · 1 Sept 2026
525 shares 0Class A Common Stock SEC:0001628280-26-060518:0
● Director · Executives · 1 Sept 2026
250,000 shares 0Class A Common Stock SEC:0001628280-26-060520:0
● Director · Executives · 1 Sept 2026
15,585 shares 0Class A Common Stock SEC:0001628280-26-060520:1
◇ Director · Executives · 1 Sept 2026
541 shares 0Class A Common Stock SEC:0001628280-26-060520:2
◇ Director · Executives · 1 Sept 2026
460 shares 0Class A Common Stock SEC:0001628280-26-060522:0
◇ Director · Executives · 1 Sept 2026
460 shares 0Class A Common Stock SEC:0001628280-26-060526:0
◇ Director · Executives · 1 Sept 2026
477 shares 0Class A Common Stock SEC:0001628280-26-060508:0
◇ Director · Executives · 1 Sept 2026
493 shares 0Class A Common Stock SEC:0001628280-26-060511:0
◇ Director · Executives · 1 Sept 2026
477 shares 0Class A Common Stock SEC:0001628280-26-060514:0
◇ Director · Executives · 1 Sept 2026
477 shares 0Class A Common Stock SEC:0001628280-26-060516:0
◇ Pres. & Chief Customer Officer · Executives · 27 Aug 2026
10,000 shares @ US$154.00 0.0034% mcap 7.0% of flow Class A Common Stock SEC:0001628280-26-059612:0
▼ Pres. & Chief Customer Officer · Executives · 27 Aug 2026
10,000 shares @ US$281.33 0.0063% mcap 12.7% of flow Class A Common Stock SEC:0001628280-26-059612:1
▼ Pres. & Chief Customer Officer · Executives · 13 Aug 2026
1,000 shares @ US$241.91 0.0006% mcap 1.4% of flow Class A Common Stock SEC:0001628280-26-057403:0
◇ Pres. & Chief Customer Officer · Executives · 13 Aug 2026
35,000 shares @ US$154.00 0.014% mcap 30.7% of flow Class A Common Stock SEC:0001628280-26-057403:1
▼ Pres. & Chief Customer Officer · Executives · 13 Aug 2026
33,181 shares @ US$250.4403 0.021% mcap 47.3% of flow Class A Common Stock SEC:0001628280-26-057403:2
▼ Pres. & Chief Customer Officer · Executives · 13 Aug 2026
1,819 shares @ US$251.028 0.0012% mcap 2.6% of flow Class A Common Stock SEC:0001628280-26-057403:3
▼ Pres. & Chief Customer Officer · Executives · 16 Jul 2026
5,000 shares @ US$200.00 0.0031% mcap 31.7% of flow Class A Common Stock SEC:0001628280-26-048823:0
● SVP, Gen. Counsel, Secretary · Executives · 1 Jul 2026
832 shares @ US$184.22 0.0005% mcap 6.2% of flow Class A Common Stock SEC:0001628280-26-047262:1
● Chief Accounting Officer · Executives · 1 Jul 2026
60 shares @ US$184.22 0.0000% mcap 100.0% of flow Class A Common Stock SEC:0001628280-26-047266:1
● Pres. & Chief Customer Officer · Executives · 1 Jul 2026
1,117 shares @ US$184.22 0.0007% mcap 11.7% of flow Class A Common Stock SEC:0001628280-26-047268:1
● Chief Financial Officer · Executives · 1 Jul 2026
693 shares @ US$184.22 0.0004% mcap 100.0% of flow Class A Common Stock SEC:0001628280-26-047273:1
◇ Chief Accounting Officer · Executives · 1 Jul 2026
167 shares 0Class A Common Stock SEC:0001628280-26-047266:0
◇ Pres. & Chief Customer Officer · Executives · 1 Jul 2026
2,907 shares 0Class A Common Stock SEC:0001628280-26-047268:0
◇ Chief Financial Officer · Executives · 1 Jul 2026
1,635 shares 0Class A Common Stock SEC:0001628280-26-047273:0
◇ SVP, Gen. Counsel, Secretary · Executives · 1 Jul 2026
1,635 shares 0Class A Common Stock SEC:0001628280-26-047262:0
25 of 583 declarations
Load more (558 remaining) 关于 Veeva Systems INC Veeva Systems Inc. 是一家总部位于美国的企业软件公司,专注于为全球生命科学行业提供云软件、数据、人工智能和咨询服务。该公司在美国纽约证券交易所上市,股票代码为 VEEV。公司成立于 2007 年,总部位于美国加利福纳州普莱森顿。
Veeva 的商业模式围绕一个垂直行业平台构建,该平台旨在满足制药、生物技术公司和其他高度受监管的生命科学组织的运营、监管和商业需求。其核心产品堆栈涵盖 Vault Platform、Vault CRM、Veeva Quality Cloud、Veeva Clinical、Veeva Regulatory、Veeva Safety、Veeva Medical、Veeva Commercial Cloud 和 Veeva Data Cloud。最近,该公司一直在大力推广 Veeva AI,这是一套旨在深入 Veeva 应用程序内部工作的特定领域人工智能功能和代理。这具有战略重要性,因为 Veeva 销售的不是通用软件;它提供的是针对生命科学价值链量身定制的、工作流繁重且符合法规要求的应用程序。
从竞争角度来看,Veeva 在生命科学垂直云软件领域占据领先地位。其护城河得益于行业专业化、长期的客户关系、经常性订阅收入以及其平台的广度,该平台涵盖研发、临床运营、质量、法规、医疗事务和商业执行。在最近的公司通讯中,Veeva 强调了 Vault CRM 的扩展、新兴生物技术公司对 Veeva Basics 的日益采用,以及人工智能赋能产品早期的发展势头。这种组合巩固了该公司作为关键任务供应商而非可自由支配的 IT 提供商的声誉。
从地理上看,Veeva 为全球客户提供服务,在多个地区拥有商业足迹和支持能力,同时将其公司基地设在加利福尼亚。最近值得关注的发展包括在应用程序中推出 Veeva AI Agents、推出新的以生物技术为重点的产品、与临床试验创新相关的合作公告,以及 2025 年和 2026 年初强劲的季度业绩,这得益于稳健的订阅收入增长。对于投资者而言,Veeva 在健康与制药领域中脱颖而出,成为一家高质量的成长型公司,受益于结构性弹性终端市场,并拥有基于深厚领域专业知识的差异化软件特许经营权。